Fennec Pharmaceuticals Inc

NASDAQ:FENC  
6.32
+0.12 (+1.94%)
Earnings Announcements

Fennec Announces Fiscal Year 2020 Financial Results And Provides Business Update

Published: 03/30/2021 11:20 GMT
Fennec Pharmaceuticals Inc (FENC) - Fennec Announces Fiscal Year 2020 Financial Results and Provides Business Update.
Fennec Pharmaceuticals Inc - Resubmission of NDA for Pedmark is Planned for Q2 of 2021.
Fennec Pharmaceuticals Inc - Cash and Cash Equivalents on Hand As of Dec.
31, 2020 Will Be Sufficient to Fund Co's Planned Activities for 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.18

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.20

More details on our Analysts Page.